中风与神经疾病杂志2024，Vol.41Issue(7)：586-588,3.DOI:10.19845/j.cnki.zfysjjbzz.2024.0113
偏头痛发病机制及生物标志物研究进展
Research advances in the pathogenesis and biomarkers of migraine
毛西京 1朱博驰 1于挺敏1
作者信息
- 1. 吉林大学第二医院,吉林 长春 130000
- 折叠
摘要
Abstract
Migraine is a heterogeneous disease with various subtypes,and the diagnosis of migraine mainly relies on clinical criteria.The lack of specific biomarkers for objective assessment impacts the precise diagnosis,treatment selec-tion,and prognostic assessment of migraine.In recent years,great progress has been made in migraine in terms of genet-ics,biochemistry,and imaging,which provides objective indicators for the clinical diagnosis and treatment of migraine.Identifying specific,sensitive,easily detectable,and highly feasible markers in clinical practice will accelerate the early di-agnosis and precise treatment of migraine.关键词
偏头痛/生物标志物/神经元/胶质细胞Key words
Migraine/Biomarkers/Neurons/Glial cells分类
医药卫生引用本文复制引用
毛西京,朱博驰,于挺敏..偏头痛发病机制及生物标志物研究进展[J].中风与神经疾病杂志,2024,41(7):586-588,3.
